Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosite Triage ProfilER symptom panel

This article was originally published in The Gray Sheet

Executive Summary

Shipments of the "shortness-of-breath" test panel to distinguish among congestive heart failure, pulmonary embolism and heart attack will begin after the product debuts at the American Association for Clinical Chemistry annual meeting in Los Angeles July 25-29. Within 15 minutes, ER test-givers can measure five biomarkers: BNP, D-dimer, myoglobin, CK-MB and troponin I (1"The Gray Sheet" May 10, 2004, p. 23). The panel will "eliminate the need for the hospital to obtain multiple blood samples or employ one or more laboratory-based analyzers to accomplish multiple tests," Biosite states in a June 30 release announcing 510(k) clearance. The San Diego firm is emphasizing the assay's potential to combat "overcrowding" in emergency departments...
Advertisement

Related Content

Cardiac Markers Clash For Hospital, Lab Space: Biosite Triages R&D Projects
Cardiac Markers Clash For Hospital, Lab Space: Biosite Triages R&D Projects
Advertisement
UsernamePublicRestriction

Register

MT020492

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel